NDC 72060-121

CAPLYTA

Lumateperone

CAPLYTA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Intra-cellular Therapies, Inc. The primary component is Lumateperone.

Product ID72060-121_574a3159-32b9-42b8-a653-bee24406fe38
NDC72060-121
Product TypeHuman Prescription Drug
Proprietary NameCAPLYTA
Generic NameLumateperone
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2022-08-09
Marketing CategoryNDA /
Application NumberNDA209500
Labeler NameIntra-Cellular Therapies, Inc
Substance NameLUMATEPERONE
Active Ingredient Strength21 mg/1
Pharm ClassesAtypical Antipsychotic [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 72060-121-40

30 CAPSULE in 1 BOTTLE (72060-121-40)
Marketing Start Date2022-08-09
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "CAPLYTA" or generic name "Lumateperone"

NDCBrand NameGeneric Name
70518-3497CAPLYTAlumateperone
72060-110CAPLYTAlumateperone
72060-121CAPLYTAlumateperone
72060-142CAPLYTAlumateperone

Trademark Results [CAPLYTA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CAPLYTA
CAPLYTA
88742518 not registered Live/Pending
INTRA-CELLULAR THERAPIES, INC.
2019-12-30
CAPLYTA
CAPLYTA
88742498 not registered Live/Pending
INTRA-CELLULAR THERAPIES, INC.
2019-12-30
CAPLYTA
CAPLYTA
88340176 not registered Live/Pending
INTRA-CELLULAR THERAPIES, INC.
2019-03-14
CAPLYTA
CAPLYTA
87334055 not registered Live/Pending
INTRA-CELLULAR THERAPIES, INC.
2017-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.